ANGELA DOIRON: Open Payments
NPI 1073511960 · MORGAN CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 41 payments from 9 companies in 2025. Trend: 2023 $1,109 · 2024 $935 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $155 |
| ABBVIE INC. | 6 | $107 |
| Novo Nordisk Inc | 5 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Lilly USA, LLC | 3 | $61 |
| Corium, LLC | 3 | $42 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: ELIQUIS, TRINTELLIX, UBRELVY, MOUNJARO, Ozempic, AIRSUPRA, Azstarys, BREZTRI.
Industry payments across LA — which companies pay providers there.
